Plasmid DNA encoding IFN-α1 antagonizes herpes simplex virus type I ocular infection through CD4+ and CD8+ T lymphocytes

Journal of Immunology

Volumn 164, Issue 12, 2000, Pages 6435-6443

  Noisakran, Sansanee ^a   Carr, Daniel J J ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; EXTRAOCULAR MUSCLE; EYE INFECTION; EYE PROTECTION; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TRANSGENE; TRIGEMINUS GANGLION; VIRUS IMMUNITY;

EID: 0034660552     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.12.6435     Document Type: Article

References (70)

1. Su, Y.-H., X.-T. Yan, J. E. Oakes, and R. N. Lausch. 1996. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. J. Virol. 70:1277.
2. Tumpey, T. M., H. Cheng, D. N. Cook, O. Smithies, J. E. Oakes, and R. N. Lausch. 1998. Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis. J. Virol. 72:3705.
3. Yan, X.-T., T. M. Tumpey, S. L. Kunkel, J. E. Oakes, and R. N. Lausch. 1998. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest. Ophthalmol. Vis. Sci. 39:1854.
4. Tumpey, T. M., S.-H. Chen, J. E. Oakes, and R. N. Lausch. 1996. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:898.
5. Thomas, J., S. Gangappa, S. Kanangat, and B. T. Rouse. 1997. On the essential involvement of neutrophils in the immunopathologic disease. Herpetic stromal keratitis. J. Immunol. 158:1383.
6. Bouley, D. M., S. Kanangat, and B. T. Rouse. 1996. The role of the innate immune system in the reconstituted SCID mouse model of herpetic stromal keratitis. Clin. Immunol. Immunopathol. 80:23.
7. Brandt, C. R., and C. A. Salkowski. 1992. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1. Invest. Ophthalmol. Vis. Sci. 33:113.
8. Adler, H., J. L. Beland, N. C. Del-Pan, L. Kobzik, R. A. Sobel, and I. J. Rimm. 1999. In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. J. Neuroimmunol. 93:208.
9. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation of innate cytokines. Annu. Rev. Immunol. 17:189.
10. Niemialtowski, M. G., and B. T. Rouse. 1992. Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J. Immunol. 148:1864.
11. Tang, Q., and R. L. Hendricks. 1996. Interferon-γ regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J. Exp. Med. 184:1435.
12. Tang, Q., W. Chen, and R. L. Hendricks. 1997. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J. Immunol. 158:1275
13. Bouley, D. M., S. Kanangat, W. Wire, and B. T. Rouse. 1995. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice. J. Immunol. 155:3964.
14. Cantin, E., B. Tanamachi, H. Openshaw, J. Mann, and K. Clarke. 1999. γ-Interferon (TFN-γ) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-γ ligand null-mutant mice. J. Virol. 73:5196.
15. Geiger, K. D., T. C. Nash, S. Sawyer, T. Krahl, G. Patstone, J. C. Reed, S. Krajewski, D. Dalton, M. J. Buchmeier, and N. Sarvetnick. 1997. Interferon-γ protects against herpes simplex virus type 1-mediated neuronal death. Virology 238:189.
16. Staats, H. F., and R. N. Lausch. 1993. Cytokine expression in vivo duringmurine herpetic stromal keratitis. J. Immunol. 151:277.
17. Cubitt, C. L., R. N. Lausch, and J. E. Oakes. 1995. Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Vis. Sci. 36:330.
18. Kanangat, S., J. Thomas, S. Gangappa, J. S. Babu, and B. T. Rouse. 1996. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. J. Immunol. 156:1110.
19. Daigle, J., and D. J. J. Carr. 1998. Androstenediol antagonizes herpes simplex virus type 1-induced encephalitis through the augmentation of type 1 IFN production. J. Immunol. 160:3060.
20. He, J., H. Ichimura, T. Iida, M. Minami, K. Kobayasni, M. Kita, C. Sotozono, Y.-I. Tagawa, Y. Iwakura, and J. Imanishi. 1999. Kinetics of cytokine production in the cornea and trigeminal ganglion of C57BL76 mice after comeal HSV-1 infection. J. Interferon Cytokine Res. 19:615.
21. Cantin, E. M., D. R. Hinton, J. Chen, and H. Openshaw. 1995. γ-Interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:4898.
22. Shimeld, C., J. L. Whiteland, S. M. Nicholls, E. Grinfeld, D. L. Easty, H. Gao, and T. J. Hill. 1995. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61:7.
23. Halford, W. P., B. M. Gebhardt, and D. J. J. Can. 1996. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type I. J. Immunol. 157:3542.
24. Liu, T., Q. Tang, and R. L. Hendricks. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:264.
25. Shimeld, C., J. L. Whiteland, N. A. Williams. D. L. Easty, and T. J. Hill. 1997. Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J. Gen. Virol 78:3317.
26. Metcalf, J. F., J. Koga, S. Chatterjee, and R. J. Whitley. 1987. Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease. Curr. Eye Res. 6:173.
27. Beland, J. L., R. A. Sobel, H. Adler, N. C. Del-Pan, and I. J Rimm. 1999. B cell-deficient mice have increased susceptibility to HSV-1 encephalomyelitis and mortality. J. Neuroimmunol. 94:122.
28. Daheshiac M., S. Deshpande, S. Chun, N. A. Kuklin, and B. T. Rouse. 1999. Resistance to herpetic stromal keralitis in immunized B-cell-deficient mice. Virology 257:168.
29. Oakes, J. E., W. B. Davis, J. A. Taylor, and W. A. Weppner. 1980. Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice. Infect. Immun. 29:642.
30. Simmons, A., and D. C. Tscharke. 1992. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175:1337.
31. Mercadal, C. M., D. M. Bouley, D. DeStephano, and B. T. Rouse. 1993. Herpetic stromal keratitis in the reconstituted seid mouse model. J. Virol. 67:3404.
32. Sciammas, R., P. Kodukula, Q. Tang, R. L. Hendricks, and J. A. Bluestone. 1997. T cell receptor-γδ cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J. Exp. Med. 185:1969.
33. Zhao, Z:-S., F. Granucci, L. Yeh, P. A. Schaffer, and H. Cantor. 1998. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279:1344.
34. Ghiasi, H., S. Bahri, A. B. Nesburn, and S. L. Wechsler. 1995. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus I glycoproteins. Invest. Ophthalmol. Vis. Sci. 36:1352.
35. Morrison, L. A., and D. M. Knipe. 1997. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex vims type 1. Virology 239:315.
36. Karem, K. L., J. Bowen. N. Kuklin, and B. T. Rouse. 1997. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. J. Gen. Virol. 78:427.
37. Ghiasi, H., S. Cai, S. Slanina, A. B. Nesbum, and S. L. Wechsler 1997. Non-neutrilizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring inn various virus-mouse strain combinations. Invest. Ophthalmol. Vis. Sci. 38:1213.
38. Nesburn, A. B., R. L. Burke, H. Ghiasi, S. M. Slanina, and S. L. Wechsler. 1999. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits. Virology 252:200.
39. Pivetti-Pezzi, P., M. Accorinti, R. A. M. Colabelli-Gisoldi, M. P. Pirraglia, and M. C. Sirianni. 1999. Herpes simplex virus vaccine in recurrent herpetic ocular infection. Cornea 18:47.
40. Tumpey, T. M., V. M. Elner, S.-H. Chen, J. E. Oakes, and R. N. Lausch. 1994. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J. Immunol. 153:2258.
41. Daheshia, M., N. Kuklin, S. Kanangat, E. Manickan, and B. T. Rouse. 1997. Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. J. Immunol. 159:1945.
42. Hendricks, R. L., P. C. Weber, J. L. Taylor, A. Koumbis, T. M. Tumpey, and J. C. Glorioso. 1991. Endogenously produced interferon a protects mice from herpes simplex virus type 1 corneal disease. J. Gen. Virol. 72:1601.
43. Halford, W. P., L. A. Veress, B. M. Gebhardt. and D. J. J. Carr, 1997. Innate and acquired immunity to herpes simplex virus type 1. Virology 236:328.
44. Lieb, D. A., T. A. Hamson, K. M. Laslo, M. A. Machalek, N. J. Moorman, and H. W, Virgin. 1999. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189:663.
45. Noisakran, S., I. L. Campbell, and D. J. J. Carr. 1999. Ectopic expression of DNA encoding IFN-α1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis. J. Immunol. 162:4184.
46. Cui, B., and D. J. J. Carr. 2000. A plasmid construct encoding murine interferon β antagonizes the replication of herpes simplex virus type 1 in vitro and in vivo. J. Neuroimmunol. In press.
47. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, Vol. L C Nolan, ed. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, p. 133.
48. Robinson, H. L. 1997. Nucleic acid vaccines: an overview. Vaccine 15:785.
49. Chun, S., M. Daheshia, S. Lee, S. K. Eo, and B. T. Rouse. 1999. Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10. J. Immunol. 163:2393.
50. Parronchi, P., M. De Carli, R. Manetti, C. Simonelli, S. Sampognaro, M.-P. Piccinni, D. Macchia, E. Maggi, G. Del Prete, and S. Romagnani. 1992. IL-4 and IFN (α and γ) exert opposite regulatory aspects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149:2977.
51. Demeure, C. E., C. Y. Wu, U. Shu, P. V. Schneider, C. Heusser, H. Yssel, and G. Delespesse. 1994. In vitro maturation of human neonatal CD4 T lymphocytes. J. Immunol. 152:4775
52. Noisakran, S., I. L. Campbell, and D. J. J. Carr. 2000. IFN-α1 plasmid construct affords protection against HSV-2 infection in transfected L929 fibroblasts. J. Interferon Cytokine Res. 20:107.
53. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type 1 interferon in vivo. Science 272:1947.
54. Marrack, P., J. Kappler, and T. Mitchell. 1999. Type 1 interferons keep activated T cells alive. J. Exp. Med. 189:521.
55. Raftery, M. J., C. K. Behrens, A. Muller, P. H. Krammer, H. Walczak, and G. Schonrich. 1999. Herpes simplex virus type 1 infection of activated cytotoxic T cells: induction of fratricide as a mechanism of viral immune evasion. J. Exp. Med. 190:1103.
56. + T lymphocytes. Cell 77.525.
57. Vanguri, P., and J. M. Farber. 1990. Identification of CRG-2: an interferon-inducible mRNA predicted to encode a murine monokine. J. Biol. Chem. 265: 15049.
58. Mahalingam, S., J. M. Farber, and G. Karupiah. 1999. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol. 73:1479.
59. Taub, D. D., T. J. Sayers, C. R. D. Carter, and J. R. Ortaldo. 1995. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877.
60. Carr, D. J. J., and I. L. Campbell. 1999. Transgenic expression of interleukin-6 in the central nervous system confers protection against acute herpes simplex virus type-1 infection. J. Neurovirol. 5:449.
61. LeBlanc, R. A., L. Pesnicak, E. S. Cabral, M. Godleski, and S. E. Straus. 1999. Lack of interleukin-6 (11-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type l in IL-6 knockout mice. J. Virol. 73:8145.
62. Noisakran, S., and D. J. J. Carr. 2000. Therapeutic efficacy of DNA encoding IFN-α1 against corneal HSV-1 infection Curr. Eye Res. In press.
63. Babu, J. S., J. Thomas, S. Kanangat, L. A. Morrison, D. M. Knipe, and B. T. Rouse. 1996. Viral replicalion is required for induction of ocular immunopathology by herpes simplex virus. J. Virol. 70:101.
64. Biron, C. A., G. Sonnenfeld, and R. M. Welsh. 1984. Interferon induces natural killer cell blastogenesis in vivo. J. Leukocyte Biol. 35:31.
65. Hendrzak, J. A., and P S. Morahan. 1994. The role of macrophages and macrophages cytokines in host resistance to herpes simplex virus. Immunol. Ser. 60:601.
66. + T cells. J. Exp. Med. 178:1655.
67. Richards, C. M., C. Shimeld, N. A. Williams, and T. J. Hill. 1998. Induction of mucosal immunity against herpes simplex virus type 1 in the mouse protects against ocular infection and establishment of latency. J. Infect. Dis. 177:1451
68. Chun, S., M. Daheshia, N. A. Kuklin, and B. T. Rouse. 1998. Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routes. J. Virol. 72:5545.
69. Horton, H. M., D. Anderson, P. Hernandez, K. M. Barnhart, J. A. Norman, and S. E. Parker. 1999. A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon α. Proc. Natl. Acad. Sci. USA 96:1553.
70. Horton, H. M., O. Dorigo, P. Hernandez, D. Anderson, J. S. Berek, and S. E. Parker. 1999. IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile. J. Immunol. 163:6378.